In recent weeks, the U.S. Department of Health and Human Services (HHS) has invested more than $562 million into U.S. companies to boost domestic manufacturing of COVID-19 tests and supplies.
These funds, pulled from the American Rescue Plan Act, have benefited supplies such as pipette tips, protective packaging, swabs, and reagents for detecting the SARS-CoV-2 virus in samples. This, the Biden administration hopes, will actively expand COVID-19 testing capabilities and reinvigorate the supply chain while guaranteeing tests that are both high quality and easily used. So far, a dozen U.S. companies have benefited from these investments.
Recipients included:
In all, according to President Joe Biden, the administration will move to invest as much as $3 billion into rapid testing efforts. The goal will be to quadruple the supply of at-home tests by December and increase the number of free testing sites.
A Department of Defense (DoD) 2040 Task Force (D2T) challenge on talent management innovation drew…
For the first time since its creation in 2004, the Transportation Security Administration’s (TSA) Flight…
The 2024 Hurricane Season Campaign began for the Federal Emergency Management Agency (FEMA) this week,…
As a way to support veterans, U.S. Reps. Maria Elvira Salazar (R-FL), Dale Strong (R-AL),…
Mere days after the Department of Homeland Security formed a new Artificial Intelligence (AI) Safety…
KBR will continue to provide life support, equipment readiness, training and supply chain solutions for…
This website uses cookies.